Cargando…
The monosialoganglioside GM1a protects against complement attack
The complement system is a part of the innate immune system in the fluid phase and efficiently eliminates pathogens. However, its activation requires tight regulation on the host cell surface in order not to compromise cellular viability. Previously, we showed that loss of placental cell surface sia...
Autores principales: | Wedekind, Henri, Beimdiek, Julia, Rossdam, Charlotte, Kats, Elina, Wittek, Vanessa, Schumann, Lisa, Sörensen-Zender, Inga, Fenske, Arno, Weinhold, Birgit, Schmitt, Roland, Tiede, Andreas, Büttner, Falk F. R., Münster-Kühnel, Anja, Abeln, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600102/ https://www.ncbi.nlm.nih.gov/pubmed/37880236 http://dx.doi.org/10.1038/s41420-023-01686-6 |
Ejemplares similares
-
Sialylation Is Dispensable for Early Murine Embryonic Development in Vitro
por: Abeln, Markus, et al.
Publicado: (2017) -
Monosialoganglioside GM1 reduces toxicity of Ptx and increase anti-metastasic effect in a murine mammary cancer model
por: Leonhard, Victoria, et al.
Publicado: (2020) -
Monosialoganglioside-GM1 triggers binding of the amyloid-protein salmon calcitonin to a Langmuir membrane model mimicking the occurrence of lipid-rafts
por: Diociaiuti, Marco, et al.
Publicado: (2016) -
Transdermal monosialoganglioside with laser in the treatment of spinal cord lesion in rats
por: de Souza, Fabiano Inácio, et al.
Publicado: (2013) -
Scientific literature addressing detection of monosialoganglioside: A 10-year bibliometric analysis☆
por: Xu, Yanli, et al.
Publicado: (2012)